-DOCSTART- -X- O
Transplantation -X- _ O
of -X- _ O
myogenic -X- _ O
stem -X- _ O
cells -X- _ O
possesses -X- _ O
great -X- _ O
potential -X- _ O
for -X- _ O
long-term -X- _ O
repair -X- _ O
of -X- _ O
dystrophic -X- _ O
muscle. -X- _ O
However -X- _ O
, -X- _ O
a -X- _ O
single -X- _ O
donor -X- _ O
muscle -X- _ O
biopsy -X- _ O
is -X- _ O
unlikely -X- _ O
to -X- _ O
provide -X- _ O
enough -X- _ O
cells -X- _ O
to -X- _ O
effectively -X- _ O
transplant -X- _ O
the -X- _ O
muscle -X- _ O
mass -X- _ O
of -X- _ O
a -X- _ O
patient -X- _ O
affected -X- _ O
by -X- _ O
muscular -X- _ O
dystrophy. -X- _ O
Expansion -X- _ O
of -X- _ O
cells -X- _ O
ex -X- _ O
vivo -X- _ O
using -X- _ O
traditional -X- _ O
culture -X- _ O
techniques -X- _ O
significantly -X- _ O
reduces -X- _ O
engraftment -X- _ O
potential. -X- _ O
We -X- _ O
hypothesized -X- _ O
that -X- _ O
activation -X- _ B-Intervention
of -X- _ I-Intervention
Notch -X- _ I-Intervention
signaling -X- _ I-Intervention
during -X- _ I-Intervention
ex -X- _ I-Intervention
vivo -X- _ I-Intervention
expansion -X- _ I-Intervention
would -X- _ O
maintain -X- _ O
donor -X- _ O
cell -X- _ O
engraftment -X- _ O
potential. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
expanded -X- _ O
freshly -X- _ O
isolated -X- _ O
canine -X- _ B-Patient
muscle-derived -X- _ I-Patient
cells -X- _ I-Patient
on -X- _ O
tissue -X- _ O
culture -X- _ O
plates -X- _ O
coated -X- _ O
with -X- _ O
Delta-1 -X- _ O
( -X- _ O
ext -X- _ O
) -X- _ O
-IgG -X- _ O
to -X- _ O
activate -X- _ B-Intervention
Notch -X- _ I-Intervention
signaling -X- _ I-Intervention
or -X- _ O
with -X- _ O
human -X- _ B-Comparison
IgG -X- _ I-Comparison
as -X- _ I-Comparison
a -X- _ I-Comparison
control. -X- _ I-Comparison
A -X- _ O
model -X- _ O
of -X- _ O
canine-to-murine -X- _ O
xenotransplantation -X- _ O
was -X- _ O
used -X- _ O
to -X- _ O
quantitatively -X- _ O
compare -X- _ O
canine -X- _ O
muscle -X- _ O
cell -X- _ O
engraftment -X- _ O
, -X- _ O
and -X- _ O
determine -X- _ O
if -X- _ O
engrafted -X- _ O
donor -X- _ O
cells -X- _ O
could -X- _ O
function -X- _ O
as -X- _ O
satellite -X- _ O
cells -X- _ O
in -X- _ O
vivo. -X- _ O
We -X- _ O
show -X- _ O
that -X- _ O
Delta-1 -X- _ B-Outcome
( -X- _ I-Outcome
ext -X- _ I-Outcome
) -X- _ I-Outcome
-IgG -X- _ I-Outcome
inhibited -X- _ I-Outcome
differentiation -X- _ I-Outcome
of -X- _ I-Outcome
canine -X- _ I-Outcome
muscle- -X- _ I-Outcome
derived -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
increased -X- _ I-Outcome
the -X- _ I-Outcome
level -X- _ I-Outcome
of -X- _ I-Outcome
genes -X- _ I-Outcome
normally -X- _ I-Outcome
expressed -X- _ I-Outcome
in -X- _ I-Outcome
myogenic -X- _ I-Outcome
precursors. -X- _ I-Outcome
Moreover -X- _ I-Outcome
, -X- _ I-Outcome
cells -X- _ I-Outcome
expanded -X- _ I-Outcome
on -X- _ I-Outcome
Delta-1 -X- _ I-Outcome
( -X- _ I-Outcome
ext -X- _ I-Outcome
) -X- _ I-Outcome
-IgG -X- _ I-Outcome
resulted -X- _ I-Outcome
in -X- _ I-Outcome
a -X- _ I-Outcome
significant -X- _ I-Outcome
increase -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
number -X- _ I-Outcome
of -X- _ I-Outcome
donor-derived -X- _ I-Outcome
fibers -X- _ I-Outcome
, -X- _ I-Outcome
as -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
cells -X- _ I-Outcome
expanded -X- _ I-Outcome
on -X- _ I-Outcome
human -X- _ I-Outcome
IgG -X- _ I-Outcome
, -X- _ I-Outcome
reaching -X- _ I-Outcome
engraftment -X- _ I-Outcome
levels -X- _ I-Outcome
similar -X- _ I-Outcome
to -X- _ I-Outcome
freshly -X- _ I-Outcome
isolated -X- _ I-Outcome
cells. -X- _ I-Outcome
Importantly -X- _ I-Outcome
, -X- _ I-Outcome
cells -X- _ I-Outcome
expanded -X- _ I-Outcome
on -X- _ I-Outcome
Delta-1 -X- _ I-Outcome
( -X- _ I-Outcome
ext -X- _ I-Outcome
) -X- _ I-Outcome
-IgG -X- _ I-Outcome
engrafted -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
recipient -X- _ I-Outcome
satellite -X- _ I-Outcome
cell -X- _ I-Outcome
niche -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
contributed -X- _ I-Outcome
to -X- _ I-Outcome
further -X- _ I-Outcome
regeneration. -X- _ I-Outcome
A -X- _ O
similar -X- _ O
strategy -X- _ O
of -X- _ O
expanding -X- _ O
human -X- _ O
muscle-derived -X- _ O
cells -X- _ O
on -X- _ O
Notch -X- _ O
ligand -X- _ O
might -X- _ O
facilitate -X- _ O
engraftment -X- _ O
and -X- _ O
muscle -X- _ O
regeneration -X- _ O
for -X- _ O
patients -X- _ O
affected -X- _ O
with -X- _ O
muscular -X- _ O
dystrophy -X- _ O
. -X- _ O

